Natural history and staging of chronic myelogenous leukemia

Research output: Contribution to journalReview article

82 Scopus citations

Abstract

The natural history of CML has changed in recent years, partly due to earlier diagnosis but mostly as a consequence of the availability of effective therapies that have the potential to eradicate the Ph chromosomepositive clone. Highly effective therapy with imatinib has changed the prognostic significance of clinical features traditionally associated with poor outcome. Achieving a complete cytogenetic response and a major molecular response early during the course of therapy with imatinib may be the most important factor in determining long-term outcome. Therefore, treatment modalities that increase the probability of achieving this goal should be pursued.

Original languageEnglish (US)
Pages (from-to)569-584
Number of pages16
JournalHematology/Oncology Clinics of North America
Volume18
Issue number3
DOIs
StatePublished - Jun 1 2004
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Natural history and staging of chronic myelogenous leukemia'. Together they form a unique fingerprint.

  • Cite this